1XtalPi
2About
3Solutions
4News
5Join us
6Contact us
XtalPi’s superior AI algorithms combine with physics-based methods, while XtalPi’s advanced automation robotics accelerate chemical synthesis
XtalPi’s integrated technology platform and its expert teams of scientists and technologists help collaboration partners by delivering higher-quality preclinical candidates in a shorter amount of time.
-
989
Employees
-
700+
Scientists and technologists
-
27
Ongoing drug discovery programs
-
150+
Granted patents
XtalPi provides fully integrated drug discovery solutions as well as comprehensive chemical services
Drug Discovery
Chemistry
Solid State
Automation
Drug Discovery
Chemistry
Solid State
Automation
XtalPi in the News
-
2023-06-01
XtalPi Announces Collaboration with Lilly, Using AI + Robotics to Uncover First-in-class Therapeutics
Read More -
2023-01-11
XtalPi Names New COO for U.S. Operations, Bringing Its Autonomous Labs to Boston in Continued Global Expansion
Read More -
2022-10-27
XtalPi Announces Research Collaboration with Janssen
Read More -
2022-03-07
Fierce Medtech names XtalPi as one of its “Fierce 15” Med Tech Companies of 2021
Read More -
2021-10-27
XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target
Read More
Contact us
-
Collaboration Opportunities
-
Biologics Discovery Collaboration
-
Career Opportunities
-
Media Contact
-
Corporate ESG
-
Other Inquiries
-
Biologics Discovery Collaboration
-
Shanghai Site
-
Shenzhen Site
-
Beijing Site